Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

541
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
541
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

541
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
541
Censoring Survival Data01:09

Censoring Survival Data

507
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
507
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
Survival Curves01:18

Survival Curves

628
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
628

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.

Annals of internal medicine·2026
Same author

Reimagining Orthopaedic Research: The Musculoskeletal Adaptive Platform Trial (MAPT) Design Rationale.

The Journal of bone and joint surgery. American volume·2026
Same author

Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer.

European urology focus·2026
Same author

Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial.

Communications medicine·2026
Same author

Can Prostate Cancer Screening Reduce Mortality in Men Aged 75-79 Years? A Protocol for Target-trial Emulation.

European urology open science·2025
Same author

Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial.

Communications medicine·2025

相关实验视频

Updated: Jan 10, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

基于模拟的贝叶斯预测成功概率对临床试验与竞争事件数据的临时监测:两个案例研究

Chiara Micoli1, Alessio Crippa1, Jason T Connor2,3

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Pharmaceutical statistics
|November 25, 2025
PubMed
概括

本研究引入了一种基于模拟的新方法,用于计算具有竞争风险的临床试验的贝叶斯预测成功概率 (PPoS). 这种方法使得更好的试验优化和徒劳停止决策.

关键词:
贝叶斯预测成功概率的成功概率.临床试验是指临床试验中的临床试验.竞争活动的竞争活动.进行中期分析分析.

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

相关实验视频

Last Updated: Jan 10, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

科学领域:

  • 生物统计学 生物统计学
  • 临床试验设计 临床试验设计
  • 流行病学 流行病学

背景情况:

  • 贝叶斯预测成功概率 (PPoS) 对于优化临床试验设计和决策至关重要.
  • 现有的PPoS计算方法不足以处理具有竞争事件数据的临床试验.

研究的目的:

  • 开发和描述一种基于模拟的方法,用于计算PPoS在涉及竞争事件的临床试验.
  • 为利用临时数据提供一种方法来预测试验成功概率.

主要方法:

  • 用贝叶斯模型对因果特异性危险进行事件时间和事件类型的联合分布建模.
  • 采用基于模拟的程序来预测试验结果和计算PPoS.
  • 在模型参数的后面分布上数值平均成功的概率.

主要成果:

  • 拟议的方法允许在存在竞争风险的情况下计算PPoS.
  • 使用COVID-19和前列腺癌试验数据演示了该方法的应用.
  • 展示了先前的分配选择如何在各种场景下影响PPoS评估.

结论:

  • 开发的基于模拟的方法为竞争风险临床试验中的PPoS计算提供了可行的方法.
  • 这种方法可以帮助优化试验规模,并做出关于徒劳性的知情决策.
  • 该研究强调了在贝叶斯试验监测中考虑竞争事件的重要性.